Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10039946HBVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS10040735HBVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS20001818HPVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS20010059HPVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS44025444HTLV-1ENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS44016388HTLV-1ENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TCGA Plot Options
Drug Information
GeneSLC6A3
DrugBank IDDB01104
Drug NameSertraline
Target IDBE0000647
UniProt IDQ01959
Regulation Typeinhibitor
PubMed IDs9537821; 18664165; 17187269; 15181382; 9808077
CitationsTatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2-3):249-58.@@Ghanizadeh A: Sertraline-associated hair loss. J Drugs Dermatol. 2008 Jul;7(7):693-4.@@Lemke MR: [Antidepressant effects of dopamine agonists. Experimental and clinical findings]. Nervenarzt. 2007 Jan;78(1):31-8.@@Nemeroff CB, Owens MJ: Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectr. 2004 Jun;9(6 Suppl 4):23-31.@@Goodnick PJ, Goldstein BJ: Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology. J Psychopharmacol. 1998;12(3 Suppl B):S5-20.
GroupsApproved
Direct ClassificationTametralines
SMILESCN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
Pathways
PharmGKBPA451333
ChEMBLCHEMBL809